A couple of months ago MagVenture’s MagVita transcranial magnetic stimulation system received FDA approval and in 2011 it was the first TMS system approved in the European Union. It’s used to treat major depressive disorder in patients who failed to respond to other therapies. We held a live hangout with Kerry Rome, VP of Sales at MegVenture, who discussed the device with us and its applications.
Flashback: MagVenture MagVita Transcranial Magnetic Stimulation FDA Approved